Novo Nordisk says it is the world's first once-weekly basal insulin approved for clinical use, which is prescribed for the ...

Awiqli is a new insulin injection that needs to be administered only once a week. Learn from a doctor about benefits, side ...

By Rishika Sadam July 9 (Reuters) - Danish drugmaker Novo Nordisk launched its weekly basal insulin injection, Awiqli, in ...

The injection replaces the need for a daily basal insulin injection with a once-a-week dose. This reduces the annual number ...

Awiqli, the world's first once-a-week basal insulin, has been launched in India, reducing insulin injections from 365 to 52 a ...

A new once-weekly insulin option has arrived in India, offering a potential alternative to daily basal insulin injections for ...

Danish pharmaceutical company Novo Nordisk has introduced a once-weekly basal insulin injection, Awiqli, which will allow ...

India has become one of the first countries in the world to introduce Awiqli, the world's first once-a-week basal insulin ...

Danish drugmaker Novo Nordisk, launched its weekly basal insulin injection, Awiqli, in India on Thursday, aiming to compete ...

Danish drugmaker Novo Nordisk has launched Awiqli, the world’s first once-weekly basal insulin, in India. Here’s how it works ...

Danish drugmaker Novo Nordisk launched its weekly basal insulin injection, Awiqli, in India on Thursday, where diabetes rates ...

Awiqli offers adults with diabetes fewer injections while maintaining effective blood sugar control through weekly dosing.